IR.BIOCEPT.COM
Investor Relations - Biocept Inc.The Investor Relations website contains information about Biocept Inc. business for stockholders, potential investors, and financial analysts.
http://ir.biocept.com/
The Investor Relations website contains information about Biocept Inc. business for stockholders, potential investors, and financial analysts.
http://ir.biocept.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.5 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
9
SITE IP
206.200.251.19
LOAD TIME
0.453 sec
SCORE
6.2
Investor Relations - Biocept Inc. | ir.biocept.com Reviews
https://ir.biocept.com
The Investor Relations website contains information about Biocept Inc. business for stockholders, potential investors, and financial analysts.
ir.biocept.com
SEC Filings - Biocept Inc.
http://ir.biocept.com/sec.cfm
Annual Reports and Proxies. All Filings (excluding Section 16). Oct 28, 2016. File is in Briefcase. Oct 24, 2016. Ally bridge lb healthcare master fund ltd. File is in Briefcase. Oct 24, 2016. Statement of beneficial ownership. File is in Briefcase. Oct 21, 2016. Nall, michael w. File is in Briefcase. Oct 21, 2016. Chandler, marsha alpert. File is in Briefcase. Oct 21, 2016. File is in Briefcase. Oct 21, 2016. Huebner, bruce a. File is in Briefcase. Oct 21, 2016. File is in Briefcase. Oct 21, 2016.
Board of Directors - Biocept Inc.
http://ir.biocept.com/directors.cfm
Annual Reports and Proxies. David F. Hale. Chairman of the Board. Holdings: 125,835 shares. Recent Stock Transactions by David F. Hale. Oct 19, 2016. Jun 16, 2016. Disposition (Non Open Market). Jun 16, 2016. Acquisition (Non Open Market). May 4, 2016. Nov 9, 2015. Aug 24, 2015. Feb 13, 2015. Feb 10, 2014. Acquisition (Non Open Market). Feb 4, 2014. Feb 4, 2014. Michael W. Nall. President and Chief Executive Officer. Michael moved to Diagnostics after an 11 year career in the medical device and equipment...
Events & Presentations - Biocept Inc.
http://ir.biocept.com/events.cfm
Annual Reports and Proxies. Oct 21, 2016. File is in Briefcase. Nov 9, 2016. Biocept, Inc. 3Q16 Earnings Release Conference Call. Biocept, Inc. 3Q16 Earnings Release Conference Call. Please sign up for Email alerts. Aug 2, 2016. Biocept, Inc. 2Q16 Earnings Release Conference Call. May 12, 2016. Biocept, Inc. 1Q16 Earnings Release Conference Call. May 5, 2016. File is in Briefcase. Apr 13, 2016. 15th Annual Needham Healthcare Conference. Mar 14, 2016. 28th Annual ROTH Conference. Mar 9, 2016. Feb 10, 2016.
Dividend History - Biocept Inc.
http://ir.biocept.com/dividends.cfm
Annual Reports and Proxies. Annual Dividends Since 2011. Sep 29, 2016. Sep 29, 2016. Sep 29, 2016. Sep 29, 2016. The historical dividend information provided is for informational purposes only, and is not intended for trading purposes. The historical dividend information is provided by Mergent, a third party service, and Biocept Inc. does not maintain or provide information directly to this service. Total dividends per year is based on the dividend ex-date. Contact Biocept, Inc. San Diego, CA 92121.
Management - Biocept Inc.
http://ir.biocept.com/management.cfm
Annual Reports and Proxies. Michael W. Nall. President and Chief Executive Officer. Mr Nall is a healthcare executive with over 25 years of experience. He has been our President and CEO since 2013. Prior to joining Biocept, Michael served as General Manager for Clarient, a GE Healthcare Company, responsible for all commercial operations including Sales, Marketing, Client Services and Reimbursement. Holdings: 74,575 shares. Recent Stock Transactions by Michael W. Nall. Oct 19, 2016. Mar 9, 2016. Apr 30, 2...
TOTAL PAGES IN THIS WEBSITE
20
About Biocept | Biocept
http://biocept.com/company
At Biocept, we are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need all from a simple blood test, known as a liquid biopsy. Doctors are already using Biocept to establish biomarker status for thousands of patients. Contact Biocept, Inc. Biocept, Inc. Headquarters. 5810 Nancy Ridge Drive. San Diego, CA 92121. T: 858.320.8200. Toll-free: 888.332.7729.
Contact our Customer Service | Biocept
http://biocept.com/customer-service
Licenses & Certifications. 5810 Nancy Ridge Dr. San Diego, CA 92121. Contact Biocept, Inc. Biocept, Inc. Headquarters. 5810 Nancy Ridge Drive. San Diego, CA 92121. T: 858.320.8200. Toll-free: 888.332.7729. F: 858.320.8225.
Biocept Liquid Biopsy Success Stories | Biocept
http://biocept.com/patients/success-stories
Liquid Biopsy Success Stories. Biocept’s Liquid Biopsies Leads to Effective Treatment of a Heterogeneous Tumor. Can we do another biopsy? Establishing biomarker status with a simple blood test. A liquid biopsy reveals tumor heterogeneity. After considering all therapy options, Dr. Thomas decided to treat Sarah based on the results of the liquid biopsy with a combination therapy including anti-HER2 therapy and chemotherapy. Sarah responded well to this regimen and is in remission. For patients with lesion...
Careers at Biocept in San Diego | Biocept
http://biocept.com/careers
Join the Team That’s Completing the Answer. Biocept is more than just a great place to work. We are dedicated to improving outcomes for cancer patients by advancing oncology diagnostics which means we’re making a real difference in people’s lives, every day. Discover a Career Filled With Challenges and Rewards. And help us push the boundaries of molecular cancer diagnostics. Be Part of the Future of Molecular Cancer Diagnostics. Biocept is an equal opportunity employer. We provide information for physici...
Partner with Biocept | Biocept
http://biocept.com/partners
Everything You Need to Make Your Clinical Trial or Research Project a Success. Biocept collaborates with leaders in pharmaceutical development, biotechnology, academic research, and more. Unique technology for rare cell capture and genetic characterization from a blood test. The flexibility you need for modifying rare cell capture and analysis methods for unique requirements. A highly skilled, experienced team working in a CLIA-licensed and CAP-accredited laboratory to deliver the most reliable results.
Track your cancer in real time with Biocept | Biocept
http://biocept.com/patients
How can a simple blood test help you and your doctor in the fight against cancer? Today’s personalized cancer treatment. Relies on information about the specific abnormalities in your DNA (called biomarkers) that make each person’s cancer different. For years, doctors have been using tissue biopsies. Samples taken directly from tumors to find out what abnormalities are driving each person’s cancer, so they can design a treatment plan with the best chances of success. The Science Behind the Liquid Biopsy.
Understanding Liquid Biopsy for Doctors | Biocept
http://biocept.com/medical-professionals
A new option for learning about your patients’ cancer. When cancer metastasizes or spreads, it sheds cells and DNA. Fragments into the blood. Biocept has developed the most advanced method for finding. Cancer cells and DNA fragments in the blood. We use analytically and clinically validated tests to establish clinically actionable. You get the same information you would get from a tissue. Sample from a simple blood test. And because Biocept uses blood, you know you’re seeing what’s. From an initial biopsy.
TOTAL LINKS TO THIS WEBSITE
9
Bimeks
214;zel Durum Açıklamaları. 1- Bimeks yaza 3 açılışla merhaba dedi. 2- Bimeks SSH, Balon Futbolu Turnuvası şampiyonu oldu. 3- Bimeks hafta sonları Samsunsporlu. 4- Bimeks Düzce mağazası Krempark AVMde. 5- Boğaziçinde müzik ile teknoloji iç içe. 6- Bimeks Yıl Değerlendirme Toplantısı: Daha Yolun Başındayız. 7- Capital, Türkiyenin kâr haritasını çıkardı. 8- Arif Bayraktar: Deneyim duygusu hâlâ çok kıymetli. 9- Bimeksten ilk çeyrekte %30 ciro büyümesi. 10- Dr. Ahmed Akgiray Ekonomiste röportaj verdi. Bimeks...
BIND Therapeutics, Inc. - Investor Relations
BIND In the News. We are a clinical-stage nanomedicine platform company developing Accurins™. A new class of targeted and programmable therapeutics developed using our Medicinal Nanoengineering. Platform. Accurins are nanoparticles designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease, enhancing efficacy while minimizing adverse effects on healthy tissues. We are developing our own pipeline. BIND Ther...
International Relations BINUS University |
International Relations BINUS University. International Relations BINUS University. International Relations BINUS University. Vision & Mission. Prospective Career of The Graduate. Quality Controlled Examinations (UPM). Luh Nyoman Ratih Wagiswari Kabinawa. Journal of ASEAN Studies. Impact and Media Coverage. Journal of ASEAN Stud. The Journal of ASEAN Studies is pleased to present our new edition: Volume 3, Number 1, published in the first half of 2015. This is the fifth pub. SCG Young Leaders Program.
Investors Overview | Bioblast Pharma
Our Platforms and Pipeline. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ - "ORPN") committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Founded in 2012, the company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical need for incurable rare diseases. SCA3 POC - 2015 International Ataxia Research Conference. SMA-BBrm02 POC - CureSMA Meeting 2015. TEL AVIV, ...
Investors Overview | Bioblast Pharma
Thomas I. H. Dubin. Bioblast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ - "ORPN") committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Our therapeutic platforms are based on deep understanding of the disease-causing biological processes, and can potentially offer solutions for several diseases that share the same biological pathology. SCA3 POC - 2015 International Ataxia Research Conference. November 29, 2016. Biobl...
Investor Relations - Biocept Inc.
Annual Reports and Proxies. Aug 11, 2015. Biocept and University of California, Irvine to Study Blood-based Liquid Biopsy Testing in Cancer Patients. Aug 10, 2015. Biocept Reports Second Quarter 2015 Financial Results. View all press releases ». Sep 9, 2015. Biocept presents at the Rodman and Renshaw 17th Annual Global Investment Conference. View all events and presentations ». Contact Biocept, Inc. Biocept, Inc. Headquarters. 5810 Nancy Ridge Drive, Suite 150. San Diego, CA 92121. T: 858.320.8200.
(주)바이오니아
인사 및 복리 후생. 단신) 2018 MEDLAB 참가. HIV-1 Kit 올해 . 인증획득 기대. 박한오 대표, . POC 분자진단 기술 발표. 탈모방지 기능성화장품 개발 . 진행중.
Investor Relations :: Bionik Laboratories Corp. (BNKL)
Navigate Bionik Laboratories Corp. Bionik Laboratories Advances InMotion AnkleBot into Commercial Development. Dec 20, 2016. Sep 30, 2016. Sign Up for E-Mail Alerts. Be the first to receive breaking news. Each of Bionik’s products are or are expected to be designed to continually adapt to a patient’s ability and provide real time feedback to the physiotherapist through the use of Bionik’s proprietary data collection and analytics cloud network through its partnership with IBM. Officers & Directors. Mr Bl...
Bioptron Light Therapy - Official Web Site
پیشرفتی انقلابی در علم پزشکی. تسکین درد و کاهش شدت آن. کاربردهای وسیع با استفاده آسان. دوره درمانی کوتاه و بدون درد. بدون عوارض جانبی شناخته شده. برای کسب اطلاعات بیشتر لطفا با توزیع کننده زپتر در محل خود تماس بگیرید. میلیونها مصرف کننده رضایتمند.
به اتاق تهاتر ايمني زيستي ايران خوش آمديد
Sign up for an account. اتاق تهاترایمنی زیستی ایران. در باره جمهوري اسلامي ايران. تصمیمات و بیانیه ها. پروژه توانمندسازي ايمني زيستي براي اجراي چارچوب ملي ايمني زيستي. سازمان ثبت و گواهي بذر. وزارت بهداشت، درمان و آموزش پزشكي. سازمان حفاظت محيط زيست. وزارت علوم، تحقيقات و فناوري. به اتاق تهاتر ايمني زيستي ايران خوش آمديد. به دليل اهميت BCH در اجراي پروتكل، اتاق تهاتر ملي ايمني زيستي تحث پروژه توانمندسازي UNEP-GEF براي مشاركت موثر كشورها در اتاق تهاتر ايمني زيستي ايجاد گرديد. روز شمار ايمني زيستي ايران.
Overview
BioScrip also offers complete Pharmacy Benefit Management programs that include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes. 160; 0.07. Data as of 08/07/15 4:00 pm ET. Q2 2015 BioScrip Earnings Conference Call. 160;at 8:30 am ET. 08/10/15 8:30 am ET. Q2 2015 BioScrip Earnings Conference Call. BioScrip To Host 2015 Second Quarter Results Call. 2014 Annual Report on Form 10-K. Elmsford, NY 10583.
SOCIAL ENGAGEMENT